Walden Group Healthcare M&A Blog

  • Agilent Technologies Purchases Resolution Bioscience in $550m Deal 

    3/15/2021
    Agilent Technologies (SYSE: A), a $5.3b analytical instrumentation development and manufacturing company, is buying Resolution Bioscience, maker of a non-invasive liquid biopsy platform, for $550m upfront plus additional milestones of up to $145m.  Resolution Bioscience’s ctDx test can detect all four major types of genetic alterations known...
    Read More
  • Hologic Pays $159m for Belgium-based Molecular Diagnostic Assay Developer Diagenode

    3/1/2021
    Hologic, a $3.8b developer of diagnostics, imaging systems, and surgical products for women's health, is buying epigenetics analysis company Diagenode, adding a menu of 30 real-time PCR (polymerase chain reaction) tests that are CE-marked for the detection of bacteria, parasites and viruses involved in sexually transmitted diseases, respiratory...
    Read More
  • The Cooper Companies Acquire AEGEA Medical

    2/16/2021
    CooperSurgical, a subsidiary of $2.4b producer of women’s health devices and contact lenses, CooperCompanies (NYSE: COO) has bought AEGEA Medical, a developer of an office-based Water Vapor Ablation System treating heavy menstrual bleeding.  The system, Mara, takes two-minutes to perform and ablates the lining of the uterus, the source of...
    Read More
  • Thermo Fisher Buys Mesa Biotech For $450m

    2/1/2021
    Thermo Fisher (NYSE: TMO) is acquiring Mesa Biotech, developer of a PCR-based rapid point-of-care (PoC) testing platform for infectious diseases.  Mesa Biotech’s Accula System has received Emergency Use Authorization (EUA) for SARS-CoV-2 in vitro diagnostic testing, providing results within 30 minutes, with greater precision than other rapid...
    Read More
  • Steris plc Acquires Cantel Medical for $4.6b

    1/18/2021
    Steris plc (NYSE: STE), a $3.0b Ireland-based provider of sterile processing services, endoscope repair, cleaning chemistries and assurance products, announced plans to acquire Cantel Medical (NYSE:CMD), a provider of infection prevention products and services focused on endoscopy and dental customers for $4.6b.  Cantel’s largest business, its...
    Read More